de Barros e Silva, Pedro G. M.
do Nascimento, Charlene Troiani
Pedrosa, Rodrigo Pinto
Nakazone, Marcelo Arruda
do Nascimento, Michel Ulloffo
de Araújo Melo, Leiliandry
Júnior, Osvaldo Lourenço Silva
Zimmermann, Sérgio Luiz
de Melo, Rodrigo Morel Vieira
Bergo, Ricardo Reinaldo
Precoma, Dalton Bertolim
Tramujas, Lucas
Lima, Eduardo Gomes
Dantas, João Miguel Malta
do Amaral Baruzzi, Antônio Cláudio
Flumignan, Ronald Luiz Gomes
de Oliveira Paiva, Maria Sanali Moura
Gowdak, Luís Henrique Wolff
de Carvalho, Priscila Nasser
de Figueiredo Neto, José Albuquerque
Silvestre, Odilson Marcos
Fioranelli, Alexandre
Vieira, Ricardo D.’Oliveira
Horak, Ana Clara Peneluppi
Miyada, Debora Harumi Kodama
Kojima, Flávia Cristina Soares
de Oliveira, Júlia Souza
de Oliveira Silva, Leila
Pavanello, Ricardo
Ramacciotti, Eduardo
Lopes, Renato D.
do Nascimento, Charlene Troiani
Pedrosa, Rodrigo Pinto
Nakazone, Marcelo Arruda
do Nascimento, Michel Ulloffo
de Araújo Melo, Leiliandry
Júnior, Osvaldo Lourenço Silva
Zimmermann, Sérgio Luiz
de Melo, Rodrigo Morel Vieira
Bergo, Ricardo Reinaldo
Precoma, Dalton Bertolim
Tramujas, Lucas
Lima, Eduardo Gomes
Dantas, João Miguel Malta
do Amaral Baruzzi, Antônio Cláudio
Flumignan, Ronald Luiz Gomes
de Oliveira Paiva, Maria Sanali Moura
Gowdak, Luís Henrique Wolff
de Carvalho, Priscila Nasser
de Figueiredo Neto, José Albuquerque
Silvestre, Odilson Marcos
Fioranelli, Alexandre
Vieira, Ricardo D.’Oliveira
Fortes, José Augusto Ribas
Ritt, Luiz Eduardo Fonteles
Requião-Moura, Lúcio R.
Borges, Fabricio Assami
Bernoche, Claudia
Pompilio, Mauricio Antonio
,
Article History
Received: 12 September 2023
Accepted: 13 February 2024
First Online: 20 February 2024
Competing interests
: PGMBS reports fees and research grants from Pfizer, Roche Diagnostics and Bayer. RDL reports research support from Bristol-Myers Squibb, GlaxoSmithKline, Medtronic, Pfizer; Consulting fees from Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi-Sankyo, GlaxoSmithKline, Medtronic, Merck, Pfizer, Portola. All other co-authors report no conflicts of interest (conflict of interest: none declared).